Anika Therapeutics | ANIK - Ação





Ação Alterar Data
Abbott USD 6.99B 501M 2026-03
Agios Pharmaceuticals USD 35.09M 2.17M 2026-03
Anika Therapeutics USD 22.84M 4.05M 2026-03
Arrowhead Research USD -173.08M 173.08M 2024-12
Halozyme Therapeutics USD 155.47M 21.01M 2026-03
Heron Therapeutics USD 54.57M 2.33M 2022-12
Insmed USD 132.91M 841K 2026-03
Integra LifeSciences USD 495.04M 2.3M 2026-03
Intrexon USD 287K 68K 2022-12
J&J USD 14.58B 392M 2026-03
Karyopharm Therapeutics USD 4.04M 72K 2025-12
Ligand Pharmaceuticals USD 13.27M 4.14M 2026-03
MacroGenics USD 9.5M 1.59M 2026-03
Merit Medical Systems USD 352.39M 18.68M 2026-03
Rigel Pharmaceuticals USD 13.3M 2.88M 2025-09
Sanofi EUR 22.69B 1.81B 2025-12
Stryker USD 5.42B 109M 2026-03
Veracyte USD 21.42M 870K 2026-03
Zimmer Biomet Holdings USD 2.25B 39.6M 2026-03